| P50 | author | Jesse D. Bloom | Q30504767 |
| | James M. McCaw | Q41045781 |
| | Aeron C. Hurt | Q42216629 |
| | Patrick C. Reading | Q45722298 |
| | Rubaiyea Farrukee | Q86451190 |
| | Alexander E Zarebski | Q91040344 |
| P2860 | cites work | Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance | Q27021579 |
| | The war against influenza: discovery and development of sialidase inhibitors | Q28259304 |
| | Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors | Q28263525 |
| | A mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal model | Q28477927 |
| | Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses | Q28541953 |
| | Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in Ferrets | Q28553195 |
| | Rational design of potent sialidase-based inhibitors of influenza virus replication | Q29616647 |
| | Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses. | Q30374927 |
| | Quantifying relative within-host replication fitness in influenza virus competition experiments. | Q30376871 |
| | A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase | Q30405350 |
| | Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective | Q30408105 |
| | Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave. | Q30419507 |
| | Viral population analysis and minority-variant detection using short read next-generation sequencing. | Q30426786 |
| | Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors | Q30438502 |
| | Kinetics of influenza A virus infection in humans | Q30445615 |
| | Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. | Q30452889 |
| | Permissive secondary mutations enable the evolution of influenza oseltamivir resistance | Q34118992 |
| | Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model | Q34120005 |
| | Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors | Q34615286 |
| | Reducing uncertainty in within-host parameter estimates of influenza infection by measuring both infectious and total viral load | Q34731272 |
| | Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer | Q34759825 |
| | Global transmission of oseltamivir-resistant influenza | Q34955928 |
| | Determination of neuraminidase kinetic constants using whole influenza virus preparations and correction for spectroscopic interference by a fluorogenic substrate | Q34971083 |
| | Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium | Q35640944 |
| | Transmission of influenza B viruses in the guinea pig. | Q35868018 |
| | Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient | Q36118639 |
| | Mouse adaptation of influenza B virus increases replication in the upper respiratory tract and results in droplet transmissibility in ferrets | Q36242184 |
| | Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. | Q36870919 |
| | Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015. | Q37710503 |
| | Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y. | Q37713074 |
| | Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics | Q37713692 |
| | NB protein does not affect influenza B virus replication in vitro and is not required for replication in or transmission between ferrets | Q37738395 |
| | Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses. | Q38149216 |
| | Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir | Q38428433 |
| | Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016. | Q38627487 |
| | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 |
| | Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds. | Q40170815 |
| | In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir | Q40911739 |
| | Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014. | Q41344703 |
| | Susceptibility of Influenza B Viruses to Neuraminidase Inhibitors Isolated during 2013-2014 Influenza Season in Mainland China | Q41594578 |
| | Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013. | Q42204936 |
| | A cluster of patients infected with I221V influenza b virus variants with reduced oseltamivir susceptibility--North Carolina and South Carolina, 2010-2011. | Q42282531 |
| | Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007. | Q43174669 |
| | Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses | Q43184619 |
| | Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir | Q43210983 |
| | A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding | Q44497218 |
| | In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors | Q45080611 |
| | Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season. | Q45947329 |
| | Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors. | Q46869332 |
| | The burden of influenza B: a structured literature review | Q57943670 |
| | Selection of influenza A and B viruses for resistance to 4-guanidino-Neu5Ac2en in cell culture | Q73551861 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Influenza B virus | Q1089532 |
| P577 | publication date | 2018-10-24 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility | |
| P478 | volume | 62 | |